Advanced Gynecological Malignancies: Clinical Trials

2 trials for Advanced Gynecological Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1

Follow Advanced Gynecological Malignancies: new trials by email Literature Review of Advanced Gynecological Malignancies trials Research Report on Advanced Gynecological Malignancies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
SKB518 for injection, Carboplatin (AUC 5), Bevacizumab - Advanced Gynecological Malignancies
Phase 2RecruitingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2802026-04-082026-05-12
Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies
BRY812 for injection - Advanced Gynecological Malignancies
Phase 2Not yet recruitingBioRay Pharmaceutical Co., Ltd.562025-12-012025-12-31

Interventions

Injections (2)  ·  Bevacizumab (1)  ·  Carboplatin (1)

Sponsors

BioRay Pharmaceutical Co., Ltd. (1)  ·  Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (1)

Countries

China (1)